Insulet Corporation (PODD): Price and Financial Metrics


Insulet Corporation (PODD)

Today's Latest Price: $227.87 USD

0.54 (-0.24%)

Updated Oct 29 12:51pm

Add PODD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

PODD Stock Summary

  • PODD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,354.77 -- higher than 97.45% of US-listed equities with positive expected earnings growth.
  • With a price/earnings ratio of 827.55, Insulet Corp P/E ratio is greater than that of about 99.13% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Insulet Corp is higher than 97.63% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Insulet Corp, a group of peers worth examining would be ENTG, SCL, SUPN, MKSI, and LOGI.
  • Visit PODD's SEC page to see the company's official filings. To visit the company's web site, go to www.insulet.com.

PODD Stock Price Chart Interactive Chart >

Price chart for PODD

PODD Price/Volume Stats

Current price $227.87 52-week high $255.39
Prev. close $228.41 52-week low $121.00
Day low $227.51 Volume 148,283
Day high $233.00 Avg. volume 528,037
50-day MA $229.03 Dividend yield N/A
200-day MA $200.82 Market Cap 14.96B

Insulet Corporation (PODD) Company Bio


Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company was founded in 2000 and is based in Billerica, Massachusetts.


PODD Latest News Stream


Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream


Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about Insulet Corp that investors may wish to consider to help them evaluate PODD as an investment opportunity.

Wearable Injectors Market 2020 Research and New Innovations in Medical Sector- Amgen, Becton, Dickinson and Company, Dexcom, Insulet Corporation

Oct 02, 2020 (Market Insight Reports) -- This Global Wearable Injectors Market Research Report Forecast 2020-2025 is a valuable source of insightful data for…

MarketWatch | October 2, 2020

Insulin Pumps Market Overview and Scope 2020 to 2027 | Key Players - Animus Corporation, Asante, Insulet Corporation, Nipro Diagnostic Inc

Global Insulin Pumps Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market share, and size. The Global Insulin Pumps Market research report provides a rational explanation to the reader to understand

OpenPR | October 1, 2020

The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Annexon Inc (NASDAQ: ANNX ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) CareDx Inc (NASDAQ: CDNA ) CTI BioPharma Corp (NASDAQ: CTIC ) I-Mab ADR (NASDAQ: IMAB ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) (the blank check company announced a business combination with oncology-focused Vincera Pharma) Mirati Th...

Benzinga | October 1, 2020

The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc (NASDAQ: XLRN ) (announced Health Canada approval of luspatercept for RBC transfusion-dependent anemia associated with beta-thalassemia) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Adial Pharmaceuticals Inc (NASDAQ: ADIL )(announced EUA for antibody test for COVID-19) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Fate Therapeutics Inc (NASDAQ: FA...

Benzinga | September 30, 2020

Insulet expands DASH launch

Insulet (PODD) announces that it has launched its Omnipod DASH System in Sweden, Finland, Norway and Denmark, and will add France, Belgium, Germany, Austria, Switzerland and Israel in the coming weeks.It previously launched the device, which provides up to three days on continuous insulin delivery, in the U.S., UK, the...

Seeking Alpha | September 21, 2020

Read More 'PODD' Stories Here

PODD Price Returns

1-mo -1.77%
3-mo 12.05%
6-mo 16.92%
1-year 55.02%
3-year 290.59%
5-year 662.11%
YTD 33.10%
2019 115.83%
2018 14.96%
2017 83.12%
2016 -0.34%
2015 -17.91%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8258 seconds.